Nvidia’s sweeping influence across the AI ecosystem has expanded far beyond its dominance in GPU hardware, with the company now emerging as one of the most active investors in the sector. In 2025 alone, Nvidia has participated in over 50 venture deals—already exceeding its 2024 total—and its corporate VC arm, NVentures, has also stepped up activity with 21 separate investments. Backed by record profits and a $4.5 trillion market cap, Nvidia is strategically using its capital to strengthen the global AI infrastructure it powers. Its portfolio spans the full AI spectrum, from foundational model developers like OpenAI, Anthropic’s Claude, and Mistral, to applied innovators such as Figure AI, Wayve, and Scale AI. These multibillion-dollar investments position Nvidia not just as a supplier of hardware but as an architect of the AI economy, embedding itself in nearly every layer of the emerging intelligence stack—from data centers to humanoid robotics to self-driving systems.
Within this surge of strategic investments, Hippocratic AI occupies a distinct position as a healthcare-focused generative AI startup. The company raised $141 million in a January 2025 Series B round at a $1.64 billion valuation, with Nvidia joining leading investors Kleiner Perkins, Andreessen Horowitz, and General Catalyst. Hippocratic AI is building large-scale language models trained for safe, patient-facing healthcare tasks such as pre-operative preparation, remote monitoring, and appointment support—areas that require precision, empathy, and regulatory alignment rather than direct diagnosis. Nvidia’s participation underscores its intent to extend AI’s reach into regulated, high-stakes verticals where trust and safety are paramount. By investing in Hippocratic AI, Nvidia not only reinforces its leadership in powering AI infrastructure but also aligns with a broader vision of applying generative intelligence responsibly within healthcare—an area poised to become one of AI’s most transformative frontiers.